Cancerappy
The AI engine Fit Assessment
BetaCancerappy effectively utilizes machine learning and AI to enhance cancer research, discover new therapeutic targets, and optimize drug discovery processes.
Blurb
Cancerappy designs and develops a platform that uses big data and artificial intelligence to help research against cancer.
HQ Location
Bilbao (Spain)
Founded
2019
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Developer of a novel artificial intelligence platform designed to optimize cancer drug development and personalized medicine. The company's algorithms are based on molecular alterations, scientific results, clinical trials, combinations of compounds, described efficacy, and competitive landscape, enabling scientists to move faster and better in their research work.